)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Tempest Therapeutics
Tempest Therapeutics (TPST) investor relations material
Tempest Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary20 Oct, 2026
Executive summary
Reconvened special meeting adjourned on October 14, 2026, after the proposal lacked sufficient votes; next session set for November 12, 2026, at 2:00 p.m. ET.
11,004,101 shares, or 74.3% of 14,806,997 shares outstanding on the May 28, 2026 record date, were represented, constituting a quorum.
Voting matters and shareholder proposals
Stockholders are asked to approve a charter amendment replacing specified supermajority voting requirements and permitting stockholder action by written consent.
Approval requires affirmative votes representing at least 75% of the votes all stockholders could cast in an annual election of directors or a class of directors.
The proposal is unchanged; the meeting was adjourned to allow more time to vote and encourage broader participation.
Shareholder rights and capital structure
Previously submitted proxies remain valid for the reconvened meeting unless properly revoked; stockholders who do not wish to change an existing vote need take no action.
The record date remains May 28, 2026; the reconvened meeting will be held by live webcast, with the same access code as the original meeting.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Tempest Therapeutics
- Two in vivo CAR-T programs pair early clinical evidence with near-term milestones.TPST
Corporate presentation - Two financing approvals could unlock capital while diluting existing stockholders.TPSTProxy filing
- Proposal One fell short of support; stockholders will reconvene November 12, 2026.TPSTAGM 2026
- Registering 9.5M shares for resale, proceeds from warrants to fund CAR-T therapy development.TPSTRegistration filing
- Shareholders will reconvene to vote on easing supermajority rules and enabling written consent actions.TPSTProxy filing
- In vivo CAR-T therapies show promising clinical results and rapid development for cancer and autoimmunity.TPSTH.C. Wainwright 28th Annual Global Investment Conference
- Up to 8.9M shares registered for resale may yield $50M in funding, with dilution risks.TPSTRegistration filing
- Shareholders will vote on easing voting thresholds and enabling action by written consent.TPSTProxy filing
- Strong clinical progress in CAR-T pipeline, but cash constraints and capital needs persist.TPSTQ2 2026
Next Tempest Therapeutics earnings date
Q3 20266 Nov, 2026
Tempest Therapeutics
Next Tempest Therapeutics earnings date
Q3 20266 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage